Heme oxygenase-1: A molecular brake on hepatocellular carcinoma cell migration

Carcinogenesis

Volumn 32, Issue 12, 2011, Pages 1840-1848

  Zou, C ^a   Zhang, H ^a   Li, Q ^a   Xiao, H ^a   Yu, L ^a   Ke, S ^b   Zhou, L ^a   Liu, W ^a   Wang, W ^b   Huang, H ^a   Ma, N ^a   Liu, Q ^c   Wang, X ^a   Zhao, W ^a   Zhou, H ^c   Gao, X ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; HEME OXYGENASE 1; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL MIGRATION; CELL STRAIN HEPG2; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC DIFFERENCE; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRACELLULAR SIGNALING; LIVER CELL CARCINOMA; LIVER METASTASIS; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEME OXYGENASE-1; HUMANS; INTERLEUKIN-6; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 81855183855     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr225     Document Type: Article

References (45)

1. Jemal,A. et al. (2011) Global cancer statistics. CA Cancer J. Clin., 61, 69-90.
2. Gueron,G. et al. (2011) Key questions in metastasis: new insights in molecular pathways and therapeutic implications. Curr. Pharm. Biotechnol.
3. Sacca,P. et al. (2004) Cell cycle arrest and modulation of HO-1 expression induced by acetyl salicylic acid in hepatocarcinogenesis. Int. J. Biochem. Cell Biol., 36, 1945-1953.
4. Liu,N. et al. (2000) Developmentally regulated expression of two transcripts for heme oxygenase-2 with a first exon unique to rat testis: control by corticosterone of the oxygenase protein expression. Gene, 241, 175-183.
5. Takahashi,T. et al. (2004) Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries. Curr. Med. Chem., 11, 1545-1561.
6. Gozzelino,R. et al. (2010) Mechanisms of cell protection by heme oxygenase-1. Annu. Rev. Pharmacol. Toxicol., 50, 323-354.
7. Jozkowicz,A. et al. (2007) Heme oxygenase-1 in tumors: is it a false friend? Antioxid. Redox Signal., 9, 2099-2117.
8. Was,H. et al. (2006) Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. Am. J. Pathol., 169, 2181-2198.
9. Lin,C.W. et al. (2008) Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9. Mol. Cancer Ther., 7, 1195-1206.
10. Kim,D.H. et al. (2009) 15-Deoxy-Delta12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS. Carcinogenesis, 30, 645-654.
11. Gueron,G. et al. (2009) Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells. Mol. Cancer Res., 7, 1745-1755.
12. Alaoui-Jamali,M.A. et al. (2009) A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer. Cancer Res., 69, 8017-8024.
13. Liu,P.L. et al. (2010) Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases. Mol. Nutr. Food Res., 54 (Suppl 2), S196-S204.
14. Dulak,J. et al. (2003) Carbon monoxide-a "new" gaseous modulator of gene expression. Acta Biochim. Pol., 50, 31-47.
15. Joung,E.J. et al. (2007) Capsaicin induces heme oxygenase-1 expression in HepG2 cells via activation of PI3K-Nrf2 signaling: NAD(P)H:quinone oxidoreductase as a potential target. Antioxid. Redox Signal., 9, 2087-2098.
16. Lee,T.S. et al. (2002) Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med., 8, 240-246.
17. Balkwill,F. et al. (2001) Inflammation and cancer: back to Virchow? Lancet, 357, 539-545.
18. Porta,C. et al. (2008) Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma. Ann. Oncol., 19, 353-358.
19. Yoshida,N. et al. (2002) Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma. Br.J.Cancer, 86, 1396-1400.
20. Chen,Z. et al. (1999) Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin. Cancer Res., 5, 1369-1379.
21. Chung,Y.C. et al. (2003) Serum interleukin-6 levels reflect the disease status of colorectal cancer. J. Surg. Oncol., 83, 222-226.
22. Wang,J. et al. (2011) Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival. J. Surg. Res., 164, e99-105.
23. Zhou,L. et al. (2010) The effect of the Gly139His, Gly143His, and Ser1 42His mouse heme oxygenase-1 mutants on the HO reaction in vivo and in vitro. Anat. Rec. (Hoboken), 294, 112-118.
24. Maeda,S. et al. (2009) Ikappa B kinasebeta/nuclear factor-kappaB activation controls the development of liver metastasis by way of interleukin-6 expression. Hepatology, 50, 1851-1860.
25. Roach,J.P. et al. (2009) Heme oxygenase-1 induction in macrophages by a hemoglobin-based oxygen carrier reduces endotoxin-stimulated cytokine secretion. Shock, 31, 251-257.
26. Motterlini,R. et al. (2002) Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ. Res., 90, E17-E24.
27. Sawle,P. et al. (2005) Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br. J. Pharmacol., 145, 800-810.
28. Hong,H.Y. et al. (2008) Up-regulation of heme oxygenase-1 expression through the Rac1/NADPH oxidase/ROS/p38 signaling cascade mediates the anti-inflammatory effect of 15-deoxy-delta 12,14-prostaglandin J2 in murine macrophages. FEBS Lett., 582, 861-868.
29. Sunamura,M. et al. (2003) Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis, 6, 15-24.
30. Vashist,Y.K. et al. (2008) Microsatellite GTn-repeat polymorphism in the promoter of heme oxygenase-1 gene is an independent predictor of tumor recurrence in male oral squamous cell carcinoma patients. J. Oral Pathol. Med., 37, 480-484.
31. Vashist,Y.K. et al. (2010) Heme oxygenase-1 promoter polymorphism is a predictor of disease relapse in pancreatic neuroendocrine tumors. J. Surg. Res., 166, e121-e127.
32. Allavena,P. et al. (2008) The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit. Rev. Oncol. Hematol., 66, 1-9.
33. Prieto,J. (2008) Inflammation, HCC and sex: IL-6 in the centre of the triangle. J. Hepatol., 48, 380-381.
34. Wong,V.W. et al. (2009) High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int. J. Cancer, 124, 2766-2770.
35. Reichner,J.S. et al. (1996) Interleukin-6 production by rat hepatocellular carcinoma cells is associated with metastatic potential but not with tumorigenicity. Arch. Surg., 131, 360-365.
36. Kapturczak,M.H. et al. (2004) Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am. J. Pathol., 165, 1045-1053.
37. Morse,D. et al. (2003) Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J. Biol. Chem., 278, 36993-36998.
38. Lad,L. et al. (2005) Crystal structures of the G139A, G139A-NO and G143H mutants of human heme oxygenase-1. A finely tuned hydrogen-bonding network controls oxygenase versus peroxidase activity. J. Biol. Inorg. Chem., 10, 138-146.
39. Ryter,S.W. et al. (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev., 86, 583-650.
40. Duckers,H.J. et al. (2001) Heme oxygenase-1 protects against vascular constriction and proliferation. Nat. Med., 7, 693-698.
41. Verma,A. et al. (1993) Carbon monoxide: a putative neural messenger. Science, 259, 381-384.
42. Brouard,S. et al. (2002) Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. J. Biol. Chem., 277, 17950-17961.
43. Petrache,I. et al. (2000) Heme oxygenase-1 inhibits TNF-alpha-induced apoptosis in cultured fibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol., 278, L312-L319.
44. De Backer,O. et al. (2009) Water-soluble CO-releasing molecules reduce the development of postoperative ileus via modulation of MAPK/HO-1 signalling and reduction of oxidative stress. Gut, 58, 347-356.
45. Genda,T. et al. (1999) Cell motility mediated by rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma. Hepatology, 30, 1027-1036.